Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 2A receptor (5-HT2A) is a G protein-coupled receptor (GPCR) subtype of the serotonin receptor family. It is widely expressed in the central nervous system (CNS) and peripheral tissues. Upon activation, it primarily couples to Gαq proteins, leading to increased production of diacylglycerol (DAG) and inositol triphosphate (IP3), stimulating protein kinase C (PKC) activity and promoting intracellular calcium release. The receptor modulates mood regulation, perception, cognition, and vascular tone. Its dysregulation has been implicated in psychiatric disorders such as depression, schizophrenia, and drug addiction. It is a target for psychoactive substances like LSD and antipsychotic drugs.
Agonism, antagonism, or inverse agonism at the 5-HT2A receptor modulate downstream signaling pathways involving Gαq, phospholipase C (PLC), diacylglycerol (DAG), inositol triphosphate (IP3), protein kinase C (PKC), and intracellular calcium (Ca2+) release, influencing neurotransmitter release, gene expression, synaptic plasticity, and vasoconstriction.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-hydroxytryptamine 2A Receptor (5-HT2A).